Reuters Pharma USA 2024 – Meruno Perugini
Innovation in pharma comes in many forms, but at the end of the day what the industry cares about is results.
Newsletters and Deep Dive digital magazine
Innovation in pharma comes in many forms, but at the end of the day what the industry cares about is results.
Anyone who has taken a psychiatric medication knows that the status quo in prescribing is a trial and error approach, with patients often cycling through an array of drugs to find the one t
The Home of Accelerating Microbial-Based Drug Development
The recent acquisition of ImmunoGen by AbbVie, which followed the earlier acquisition of Seagen by Pfizer, has brought renewed attention to antibody-drug conjugates (ADCs), highlighting the
Endeavor BioMedicines has completed a third round financing, raising an impressive $132.5 million to fund trials of its two clinical-stage drug candidates for pulmonary fi
Editor's Picks
Newsletters and Deep Dive
digital magazine